U.S. Antipsychotic Drugs Market Size, Share & COVID-19 Impact Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI109192

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 6.4% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Disease Schizophrenia Bipolar Disorder Unipolar Depression Dementia Others
	By Drug Risperidone Quetiapine Olanzapine Aripiprazole Brexpiprazole Paliperidone Palmitate Others
	By Therapeutic Class First Generation Second Generation Third Generation
	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies